
Johnson & Johnson announced that it has selected a candidate for a COVID-19 vaccine from potential constructs it has been …

Researchers examining data from over 252,000 women have concluded that there is no statistically significant link between the use of …

Healthcare conglomerate Johnson & Johnson has agreed to pay $9.9 million to settle a Washington state lawsuit over the firm’s …
Ofichem acquires US drug substance CDMO Kinentia
Jager-van Dijk is new Arletta Pharma Solutions CEOÂ
Tridem begins phase Ib trial of Parkinson’s disease vaccine

